Ascendis to widen international exposure, eyes Australian, European assets

JSE-listed Ascendis Health has set its sights on further international acquisitive growth in Australia and Europe to improve its hard currency revenue base, as it emerged from a period of consolidation within its South African operations and following the integration of its first international acquisition in Europe. The health and care company, which “proved resilient” in difficult trading conditions during the six months to December 31, said on Wednesday that the current financial year had primarily been about consolidation following numerous acquisitions in the past three years.